Last reviewed · How we verify
NCT03218878
Pregnancy Outcomes After Uterine Cavity Expansion
trial in Miscarriage in 9 participants. Completed in 10 September 2018.
1 September 2018
Quick facts
| Lead sponsor | Reproductive Medicine Associates of New Jersey |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 9 |
| Start date | 21 July 2017 |
| Primary completion | 1 September 2018 |
| Estimated completion | 10 September 2018 |
| Sites | 1 location across United States |
Conditions studied
- Miscarriage — all drugs for Miscarriage →
- Uterus Abnormal — all drugs for Uterus Abnormal →
- Infertility — all drugs for Infertility →
Sponsor
Reproductive Medicine Associates of New Jersey — full company profile →
Who can join
18 and older, female only, with Miscarriage or Uterus Abnormal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study seeks to evaluate pregnancy outcomes following hysteroscopic uterine cavity expansion surgery for patients with dysmorphic uterine cavities and poor reproductive histories. Patients already planning to undergo surgery at the recommendation of their physicians will be recruited for participation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03218878
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Miscarriage
Currently open trials in the same condition.
- NCT07109947 — Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage · NA · recruiting
- NCT06576622 — PERIodontal Disease, Microbiota and Miscarriage · recruiting
- NCT06862089 — A Prospective Study Evaluating the Impact of Conservative Management on Retained Products of Conception and EMV · recruiting
- NCT06452719 — Letrozole and Misoprostol for Early Pregnancy Loss Management · Phase 2 · recruiting
- NCT05725512 — Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages · Phase 4 · recruiting
Other Reproductive Medicine Associates of New Jersey trials
Trials by the same sponsor.
- NCT06074055 — PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer · NA · terminated
- NCT05853822 — FirmTech User Research Trial · completed
- NCT05397912 — Uterine Elastography: a Potential Predictor of Embryo Transfer Success · completed
- NCT04852029 — Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Ferti · NA · terminated
- NCT04693806 — The Effect of Embryo Culture Under a Continuous CO2 Setting Versus a Sequential CO2 Setting · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03218878 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Reproductive Medicine Associates of New Jersey
- Last refreshed: 15 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03218878.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing